Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

BACKGROUND: The outbreak and pandemic of coronavirus SARS-CoV-2 caused significant threaten to global public health and economic consequences. It is extremely urgent that global people must take actions to develop safe and effective preventions and therapeutics. Nanobodies, which are derived from si...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Qizhong, Zhang, Zongliang, Li, Hexian, Zhong, Kunhong, Zhao, Qin, Wang, Zeng, Wu, Zhiguo, Yang, Donghui, Sun, Shuang, Yang, Nian, Zheng, Meijun, Chen, Qiang, Long, Cheng, Guo, Wenhao, Yang, Hui, Nie, Chunlai, Tong, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844813/
https://www.ncbi.nlm.nih.gov/pubmed/33514385
http://dx.doi.org/10.1186/s12951-021-00768-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844813/
https://www.ncbi.nlm.nih.gov/pubmed/33514385
http://dx.doi.org/10.1186/s12951-021-00768-w

Ejemplares similares